Balyasny Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-474,518
| Closed | -$6.24M | – | 1450 |
|
|
2020
Q2 | $6.24M | Buy |
+474,518
| New | +$6.24M | 0.05% | 390 |
|
|
2020
Q1 | – | Sell |
-397,107
| Closed | -$8.22M | – | 1501 |
|
|
2019
Q4 | $8.22M | Sell |
397,107
-54,932
| -12% | -$1.14M | 0.05% | 432 |
|
|
2019
Q3 | $6.2M | Buy |
+452,039
| New | +$6.2M | 0.04% | 451 |
|
|
2019
Q1 | – | Sell |
-15,303
| Closed | -$173K | – | 1619 |
|
|
2018
Q4 | $173K | Sell |
15,303
-2,566
| -14% | -$29K | ﹤0.01% | 1209 |
|
|
2018
Q3 | $334K | Sell |
17,869
-22,131
| -55% | -$414K | ﹤0.01% | 1257 |
|
|
2018
Q2 | $1.03M | Buy |
+40,000
| New | +$1.03M | ﹤0.01% | 946 |
|
|
2018
Q1 | – | Sell |
-100,000
| Closed | -$2.5M | – | 2141 |
|
|
2017
Q4 | $2.5M | Buy |
+100,000
| New | +$2.5M | 0.01% | 865 |
|